LiqTech receives Nasdaq minimum bid price deficiency notice
LiqTech International received a deficiency notice from Nasdaq on July 21, 2026, after its common stock failed to maintain the $1 minimum bid price required for continued listing on the Nasdaq Capital Market. The company has until January 19, 2027—an initial 180 calendar day compliance period—to regain compliance by achieving a closing bid price of at least $1.00 for a minimum of ten consecutive business days. If unsuccessful, the company may be eligible for a second 180-day compliance period if it meets other listing standards, or face a delisting determination with appeal rights.
- Deficiency notice received July 21, 2026 from Nasdaq
- Minimum bid price requirement: $1.00 per share
- Initial compliance period: 180 calendar days, until January 19, 2027
- Must achieve $1.00+ closing bid for minimum ten consecutive business days to cure
- Common Stock symbol: LIQT; trading continues on Nasdaq Capital Market
- Eligible for second 180-day compliance period if other listing standards met
- If delisting determined, company may appeal to Hearings Panel
The deficiency does not trigger immediate delisting but establishes a firm compliance deadline; failure to cure by January 19, 2027 could lead to a delisting determination, which would materially affect the company's market access and trading.
Derived from 8-K filed 2026-07-24. Not investment advice. Figures are extracted from the filing; prose is AI-assisted. View the source filing on SEC.gov →